Your session is about to expire
← Back to Search
Study Summary
This trial will provide more safety data for people who are already taking venetoclax and benefiting from it.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 389 Patients • NCT02005471Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently taking venetoclax for my condition and it's working without severe side effects.I am not pregnant or breastfeeding.Not applicable.I agree not to donate sperm.
- Group 1: Venetoclax
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In how many hospitals is this research project being carried out?
"There are currently 14 centres recruiting patients for this study. For example, Dartmouth-Hitchcock Med Ctr /ID# 210555 in Lebanon, University of Michigan Health Systems /ID# 231132 in Ann Arbor, and Duplicate_Gabrail Cancer Center Research /ID# 212061 in Canton."
How many guinea pigs are participating in this trial?
"This study has completed recruitment for clinical trial candidates. The listing was first posted on September 6th, 2019 and was last updated on September 12th, 2020. There are presently 3334 clinical trials actively recruiting patients with malignancies and 226 trials for Venetoclax actively recruiting participants."
What other sorts of research has been conducted on Venetoclax in the past?
"Venetoclax was first studied in 2014 at a well-known cancer research centre. In the 6 years since, there have been 50 completed clinical trials and presently there are 226 active clinical trials. A large portion of these are based in Lebanon, New hampshire."
Share this study with friends
Copy Link
Messenger